The Obama administration urged Congress to allow the FDA to spend $41 billion in drugmaker user fees. The sequestration law limits the amount of fee-derived funds that the agency can spend, and experts warn that the agency will not be able to approve new drug and device applications quickly if the funds are subject to sequestration. Sequestration will slow progress toward cures and cost thousands of researchers their jobs, the White House warned.
White House to Congress: Exempt FDA user fees from sequester
SmartBrief Job Listings for Health Care